New analysis from Frost & Sullivan, U.S. Antimicrobial Dressings Markets, reveals that the market earned revenues of $75.4 million in 2005 and expects to reach $ 367.1 million in 2012.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Antimicrobial Dressings Markets, then send an e-mail to Melina Trevino - Corporate Communications with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.
Although antimicrobial dressings are more expensive than moist and traditional dressings, they can reduce treatment time and speed up recovery, which in turn creates cost efficiencies. The action of advocacy groups exemplifies the need for better wound management and infection control. These groups are encouraging manufacturers and healthcare facilities to utilize products that provide infection prevention and infection controls to save lives, improve patient care, and reduce treatment costs. As the rate of infections increases and spending is constrained, a greater emphasis on infection control and prevention is likely to drive sale of antimicrobial dressings.
“As a result of the increasing cost-pressures that healthcare institutions face, they have been forced to pursue new approaches to tackle rising operation costs,” says Frost & Sullivan Research Analyst Sheila Ewing. “As part of the trend that focuses on cost-efficiencies, despite their high prices when compared with moist and traditional dressings, antimicrobial dressings are gaining recognition as they reduce treatment time and speed up recovery.”
The development of antimicrobial dressings is in many ways a response to a heightened awareness and concern over increasing resistance to topical antibiotics, the emergence of 'superinfections' such as the MRSA and its various strains. With growing acceptance of a more sophisticated approach and an increased focus on infection prevention, healthcare facilities are turning to products such as antimicrobial dressings that reduce infections and provide preventive measures.
The U.S. Antimicrobial Dressings Markets is part of the Medical Devices Growth Partnership Service, and provides an overview of the effects of limited reimbursement and market consolidation, estimated revenues and market share, along with analysis of key market drivers, restraints, and trends that are impacting manufacturers’ research and development, and healthcare providers’ spending. It also includes a thorough examination of antimicrobial silver and non-silver dressings. Interviews are available to the press.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.